Additionally, patients who receive primary surgery are, if the tumor is not mucosa-limited, usually not suitable anymore for highly aggressive (radio) chemotherapy due to age or comorbidities and might therefore have a worse outcome from the beginning, which might obscure the relevance of CLDN6 expression in this subgroup. The gene discussed is CLDN6; the disease is neoplasm.